BIT
VNDA icon

BlackRock Institutional Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

BlackRock Institutional Trust’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$19.5M Buy
1,224,332
+119,021
+11% +$1.91M ﹤0.01% 1984
2016
Q3 		$18.4M Sell
1,105,311
-3,543
-0.3% -$47.7K ﹤0.01% 1951
2016
Q2 		$12.4M Buy
1,108,854
+15,575
+1% +$151K ﹤0.01% 2159
2016
Q1 		$9.14M Buy
1,093,279
+15,237
+1% +$125K ﹤0.01% 2316
2015
Q4 		$10M Buy
1,078,042
+21,677
+2% +$216K ﹤0.01% 2322
2015
Q3 		$11.9M Sell
1,056,365
-69,891
-6% -$855K ﹤0.01% 2166
2015
Q2 		$14.3M Buy
1,126,256
+15,107
+1% +$163K ﹤0.01% 2156
2015
Q1 		$10.3M Sell
1,111,149
-26,421
-2% -$299K ﹤0.01% 2377
2014
Q4 		$16.3M Buy
1,137,570
+82,929
+8% +$981K ﹤0.01% 2036
2014
Q3 		$10.9M Sell
1,054,641
-12,957
-1% -$170K ﹤0.01% 2270
2014
Q2 		$17.3M Sell
1,067,598
-12,272
-1% -$163K ﹤0.01% 2063
2014
Q1 		$17.5M Buy
1,079,870
+34,884
+3% +$496K ﹤0.01% 2052
2013
Q4 		$13M Buy
1,044,986
+41,444
+4% +$416K ﹤0.01% 2241
2013
Q3 		$11M Buy
1,003,542
+91,168
+10% +$974K ﹤0.01% 2301
2013
Q2 		$7.37M Buy
+912,374
New +$6.14M ﹤0.01% 2493

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust's VNDA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Vanda Pharmaceuticals (VNDA) stake by 11% in Q4 2016, buying an estimated $1.91M and bringing the position to 1,224,332 shares worth $19.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

BlackRock Institutional Trust first reported a position in VNDA in Q2 2013 and has held it in 15 quarters since. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • BlackRock Institutional Trust held 1,224,332 shares of Vanda Pharmaceuticals worth $19.5M as of Q4 2016.
  • BlackRock Institutional Trust bought 119,021 Vanda Pharmaceuticals shares in Q4 2016, an estimated $1.91M.
  • Vanda Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1984 holding.
  • BlackRock Institutional Trust first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.